Oral vaccines against cholera.

Abstract

The current seventh pandemic of cholera, caused by serogroup O1, El Tor biotype, has now involved almost the entire developing world. The ongoing dynamic epidemiology of cholera, involving evolution of new strains, prolonged and more frequent epidemics, increased antimicrobial resistance, and awareness of the role of climate change upon the global burden has returned cholera to the forefront of global public health discussions. Improved water and sanitation should continue to be the mainstays of cholera-prevention efforts, but major improvements are a far-off goal for much of the cholera-affected developing world. The advent of safe and effective, new-generation oral vaccines against cholera has created renewed interest in the use of vaccines as a tool to control cholera.

• Authors: Sunheang Shin, Sachin N Desai, Binod K Sah, John D Clemens
• Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis) Vol. 52 Issue 11 Pg. 1343-9 (Jun 2011) ISSN: 1537-6591 [Electronic] United States
• PMID: 21498389 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Cholera Vaccines

Topics

• Administration, Oral
• Cholera (epidemiology, immunology, prevention & control)
• Cholera Vaccines (administration & dosage, immunology)
• Communicable Disease Control (methods)
• Developing Countries
• Humans
• Pandemics (prevention & control)